Skip to main content
78°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edesa Biotech Inc
(NQ:
EDSA
)
4.450
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edesa Biotech Inc
< Previous
1
2
3
4
5
Next >
Why Edesa Biotech Shares Are Trading Higher Today
October 19, 2021
Edesa Biotech Inc (NASDAQ: EDSA) is trading higher Tuesday after the company announced additional results from the Phase 2 part of the ongoing Phase 2/3 study of EB05 in...
Via
Benzinga
Edesa Biotech Reports Favorable Mortality Reductions in COVID-19 Study
October 19, 2021
- Mortality reductions demonstrated across multiple patient groups - Additional efficacy signals recorded in a broad range of mild to severe ARDS patients - Company to focus on critically ill...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
50 Biggest Movers From Yesterday
September 22, 2021
Check out these big penny stock gainers and losers Losers Edesa Biotech, Inc. (NASDAQ: EDSA) shares dipped 29.9% to close at $8.36 on profit-taking after the stock...
Via
Benzinga
Mid-Afternoon Market Update: Dow Edges Lower; Helbiz Shares Spike Higher
September 21, 2021
Toward the end of trading Tuesday, the Dow traded down 0.11% to 33,932.34 while the NASDAQ rose 0.18% to 14,740.41. The S&P also fell, dropping 0.09% to 4,353.81. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
How To Play Edsa Biotech's Stock After 60% Surge
September 20, 2021
Edsa Biotech Inc. (NASDAQ:EDSA) shares are trading higher ...
Via
Benzinga
Mid-Day Market Update: Gold Rises 1%; Verrica Pharmaceuticals Shares Slide
September 21, 2021
Midway through trading Tuesday, the Dow traded up 0.44% to 34,119.86 while the NASDAQ rose 0.66% to 14,810.89. The S&P also rose, gaining 0.43% to 4,376.48. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
32 Stocks Moving In Tuesday's Mid-Day Session
September 21, 2021
Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 177.4% to $39.83. Helbiz Media, the media arm of Helbiz announced a deal with Amazon Italy, a unit of Amazon.com. ReWalk...
Via
Benzinga
Mid-Morning Market Update: Markets Gain; AutoZone Earnings Beat Views
September 21, 2021
Following the market opening Tuesday, the Dow traded up 0.14% to 34,017.77 while the NASDAQ rose 0.39% to 14,771.47. The S&P also rose, gaining 0.18% to 4,365.67. The U.S. has...
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...
Via
Benzinga
Exposures
COVID-19
18 Stocks Moving in Tuesday's Pre-Market Session
September 21, 2021
Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 37% to $1.78 in pre-market trading after declining around 4% on Monday. ReWalk Robotics, last month, reported Q2 sales of $1.44...
Via
Benzinga
48 Biggest Movers From Yesterday
September 21, 2021
Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized...
Via
Benzinga
EDSA Stock: The Covid-19 News Sending Edesa Biotech Soaring on Monday
September 20, 2021
Today, the announcement of positive clinical trial results has sent investors in Edesa Biotech and EDSA stock on a nice ride.
Via
InvestorPlace
Exposures
COVID-19
Why Edesa Biotech Shares Are Soaring Today
September 20, 2021
Edesa Biotech Inc (NASDAQ: EDSA) is surging higher Monday after the company announced positive Phase 2 data of its monoclonal antibody in hospitalized COVID-19 patients...
Via
Benzinga
Exposures
COVID-19
Mid-Afternoon Market Update: Dow Tumbles 2.5%; BeyondSpring Shares Plunge
September 20, 2021
Toward the end of trading Monday, the Dow traded down 2.57% to 33,696.98 while the NASDAQ fell 3.14% to 14,572.25. The S&P also fell, dropping 2.58% to 4,318.67. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Edesa Biotech Stock Is Rallying After COVID-19 Antibody Data: What You Need To Know
September 20, 2021
Edesa Biotech Inc (NASDAQ: EDSA) has announced positive results from the Phase 2 part of an ongoing Phase 2/3 study evaluating EB05 as a single-dose treatment for...
Via
Benzinga
Exposures
COVID-19
Mid-Day Market Update: Crude Oil Down 2%; Synlogic Shares Spike Higher
September 20, 2021
Midway through trading Monday, the Dow traded down 1.51% to 34,063.71 while the NASDAQ fell 2.13% to 14,723.20. The S&P also fell, dropping 1.64% to 4,360.41. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
35 Stocks Moving In Monday's Mid-Day Session
September 20, 2021
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday. Edesa Biotech, Inc. (NASDAQ: EDSA) jumped 30.6% to $7.68 after the company...
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; Brooks Automation Divests Semiconductor Business For $3B
September 20, 2021
Following the market opening Monday, the Dow traded down 1.42% to 34,093.46 while the NASDAQ fell 1.86% to 14,763.93. The S&P also fell, dropping 1.54% to 4,364.65. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
September 20, 2021
- Study unblinded due to strong efficacy signal for 28-day mortality endpoint - Critically ill patients demonstrated a 68.5% reduction in the risk of dying when treated with EB05 over Standard of Care...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Edesa Biotech to Present at the H.C. Wainwright Global Investment Conference
September 09, 2021
TORONTO, ON / ACCESSWIRE / September 9, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Edesa Biotech Provides Update For COVID-19 Antibody Trial
August 26, 2021
Edesa Biotech Inc (NASDAQ: EDSA) issued an update for the Phase 2/3 study evaluating its monoclonal antibody candidate, EB05, as single-dose therapy for...
Via
Benzinga
Exposures
COVID-19
Edesa Biotech Enrolls More Than 525 COVID-19 Patients Ahead of Schedule
August 26, 2021
- Delta variant contributes to rapid enrollment amid growing scientific rationale for targeting Toll-like Receptor 4 (TLR4) Blinded interim analysis from Phase 2/3 study expected in current quarter...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Edesa Biotech Reports Fiscal 3rd Quarter 2021 Financial Results
August 13, 2021
TORONTO, ON / ACCESSWIRE / August 13, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported financial...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Edesa Biotech Extends Dermatitis Study to Canada
July 13, 2021
TORONTO, ON / ACCESSWIRE / July 13, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that the...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Edesa Biotech Team Expands Leadership Team with Key Manufacturing Appointment
June 23, 2021
TORONTO, ON / ACCESSWIRE / June 23, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced the...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Edesa Biotech Reports Favorable Review of COVID-19 Study
June 18, 2021
TORONTO, ON / ACCESSWIRE / June 18, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported that an...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Edesa Biotech to Attend BIO Digital 2021
June 08, 2021
TORONTO, ON / ACCESSWIRE / June 8, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that the...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Edesa Biotech's EB01 Shows Encouraging Interim Results In Dermatitis Trial
June 03, 2021
Edesa Biotech Inc's (NASDAQ: EDSA) EB01 has met a key interim study parameter as part of an adaptive Phase 2b trial evaluating EB01 as monotherapy...
Via
Benzinga
Edesa Biotech Reports Positive Interim Results in Dermatitis Trial
June 03, 2021
TORONTO, ON / ACCESSWIRE / June 3, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that the...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Edesa Biotech to Join Panel Discussion at Industry Event
May 28, 2021
TORONTO, ON / ACCESSWIRE / May 28, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, announced today that Dr. Par Nijhawan, Chief Executive Officer, is scheduled to...
From
Edesa Biotech
Via
AccessWire
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.